I want a TB test that works for me
Latest News

Job Opening: Diagnostics Advisor with MSF Access Campaign read more

 

MSF shares perspective on access to medicines & innovation for this year's World Health Assembly read more

 

MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more

 

Campaign Update: Medicines Patent Pool moves closer to reality read more

 

New European Parliament Working Group on Innovation & Access launches with support of Access Campaign  read more

 





what MSF is calling for

“Starved for Attention”, MSF's malnutrition campaign is advocating for specific and targeted strategies to ensure children under two in malnutrition hotspots have access to the minimum nutrition they require.

The campaign is calling on donor governments to change current food aid programmes to meet the nutritional needs of young children and develop approaches to providing food supplements.

MSF is also highlighting the need for increased research and development into a range of supplemental foods adapted to young children's needs.

 

  • Treatment of severe acute malnutrition with therapeutic RUFs must be scaled up. Countries must develop protocols that support community-based management of severe acute malnutrition. Countries must adopt and implement the new WHO Growth Standards.


  • Funding schemes must be developed to support Ministries of Health to integrate treatment of severe acute malnutrition into their protocols and to purchase therapeutic RUFs at a price that will not break budgets.


  • Donors need to review the quality of food aid addressed towards rapidly growing young children to ensure that distributions include foods that meet their specific nutritional needs.


  • Academic and operational research must increase in order to drive the development of new complementary and supplementary foods and programme strategies aimed at meeting nutritional needs of young children, women of reproductive age and people with tuberculosis and HIV/AIDS.